Exhibit 23.1
CONSENT OF REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
Durata Therapeutics, Inc:
We consent to the use of our report dated March 8, 2013, included herein, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Short Hills, New Jersey
March 29, 2013